B
Benedetta Terziroli Beretta-Piccoli
Researcher at University of Cambridge
Publications - 49
Citations - 1358
Benedetta Terziroli Beretta-Piccoli is an academic researcher from University of Cambridge. The author has contributed to research in topics: Autoimmune hepatitis & Medicine. The author has an hindex of 14, co-authored 32 publications receiving 788 citations.
Papers
More filters
Journal ArticleDOI
Direct antiviral agent treatment of chronic hepatitis C results in rapid regression of transient elastography and fibrosis markers fibrosis‐4 score and aspartate aminotransferase‐platelet ratio index
Jacqueline A. Bachofner,Piero V. Valli,Arne Kröger,Irina Bergamin,Patrizia Künzler,Adriana Baserga,Dominique L Braun,Burkhardt Seifert,Anja Moncsek,Jan Fehr,David Semela,Lorenzo Magenta,Beat Müllhaupt,Benedetta Terziroli Beretta-Piccoli,Joachim C. Mertens +14 more
TL;DR: Transient Elastography is an ultrasound based, non‐invasive technique to assess liver stiffness (LS) and changes in TE values and fibrosis scores FIB‐4 and APRI after DAA treatment of CHC are examined.
Journal ArticleDOI
Current Perspectives on Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
TL;DR: The understanding of the pathogenesis of SJS/TEN has improved: drug-specific T cell-mediated cytotoxicity, genetic linkage with HLA- and non-HLA-genes, TCR restriction, and cytot toxicity mechanisms were clarified.
Journal ArticleDOI
Cutaneous Manifestations of Dermatomyositis: a Comprehensive Review.
TL;DR: DM subforms are discussed, focusing on their dermatological manifestations that can be classified as pathognomonic, characteristic, compatible, less common, rare, recently-described, and non-specific skin lesions.
Journal ArticleDOI
Autoimmune hepatitis: Standard treatment and systematic review of alternative treatments.
TL;DR: The aim of this review is to summarize the evidence for standard treatment and to provide a systematic review on alternative treatments for adults and children with autoimmune hepatitis.
Journal ArticleDOI
The challenges of Primary Biliary Cholangitis: what is new and what needs to be done
Benedetta Terziroli Beretta-Piccoli,Giorgina Mieli-Vergani,Diego Vergani,John M. Vierling,David H. Adams,Gianfranco Alpini,Jesus M. Banales,Ulrich Beuers,Einar Bjornsson,Christopher L. Bowlus,Marco Carbone,Olivier Chazouillères,George N. Dalekos,Andrea De Gottardi,Kenichi Harada,Gideon M. Hirschfield,Pietro Invernizzi,David Jones,Edward L. Krawitt,Antonio Lanzavecchia,Zhe-Xiong Lian,Xiong Ma,Michael Manns,Domenico Mavilio,Eamonn Martin Quigley,Federica Sallusto,Shinji Shimoda,Mario Strazzabosco,Mark G. Swain,Atsushi Tanaka,Michael Trauner,Koichi Tsuneyama,Ehud Zigmond,M. Eric Gershwin +33 more
TL;DR: New insights in interactions of bile acids with biliary epithelia in PBC provide solid evidence of a role for impaired epithelial protection against potentially toxic hydrophobic bile Acid, raising the fundamental question as to whether this bile acid-induced epithelial damage is the cause or the consequence of the autoimmune attack to the bile epithelium.